Evidence map›Paper›PMID 39885623›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2025

Brief Report: HIV Risk Perception and Pre-Exposure Prophylaxis Uptake Among Pregnant Women Offered Pre-Exposure Prophylaxis During Antenatal Care in Kenya.

Mary M Marwa, Anna Larsen, Felix Abuna, Julia Dettinger, Ben Odhiambo, Salphine Watoyi, Pascal Omondi, Nancy Ngumbau, Laurén Gómez, Grace John-Stewart and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03070600 (Delivering PrEP in Pregnancy), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03070600 phase4completednot on this map

Delivering PrEP in Pregnancy

TypeinterventionalSponsorUniversity of WashingtonRan2018 to 2021Enrolled4,447ConditionsHIV Infections, Pregnancy RelatedArmsUniversal PrEP Counseling, Targeted PrEP Counseling
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mary M MarwaDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.ORCID 0000-0002-8767-1282
Anna LarsenDepartment of Epidemiology, University of Washington, Seattle, WA.
Felix AbunaDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Julia DettingerDepartment of Global Health, University of Washington, Seattle, WA.
Ben OdhiamboDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Salphine WatoyiDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Pascal OmondiDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Nancy NgumbauDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Laurén GómezDepartment of Global Health, University of Washington, Seattle, WA.
Grace John-StewartDepartment of Epidemiology, University of Washington, Seattle, WA.
John KinuthiaDepartment of Medical Research, University of Nairobi/Kenyatta National Hospital, Nairobi, Kenya.
Jillian PintyeDepartment of Global Health, University of Washington, Seattle, WA.ORCID 0000-0003-1255-7191

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Evaluating Infant PrEP Exposure During Pregnancy and BreastfeedingR01HD100201 · NICHD · UNIVERSITY OF WASHINGTON · PI PINTYE, JILLIAN · 2019 to 2023
$3.4M
Evaluating sexually transmitted infections among adolescent girls and young women within a pharmacy-based PrEP delivery model in Kenya.R01HD108041 · NICHD · UNIVERSITY OF WASHINGTON · PI BUKUSI, ELIZABETH ANNE, PINTYE, JILLIAN · 2021 to 2025
$3.3M
mWACh-PrEP: A SMS-based Support Intervention to Enhance PrEP Adherence during Pregnancy and BreastfeedingR01NR019220 · NINR · UNIVERSITY OF WASHINGTON · PI KINUTHIA, JOHN, PINTYE, JILLIAN · 2020 to 2024
$2.9M
NIAID NIH HHS P30 AI027757NICHD NIH HHS R01 HD100201NICHD NIH HHS R01 HD108041NINR NIH HHS R01 NR019220
6 · The paper itself

Abstract

backgroundSelf-perceived HIV risk influences pre-exposure prophylaxis (PrEP) use, although few data on risk perception are available among pregnant women. We evaluated HIV risk perception and PrEP uptake among pregnant women in Kenya.

methodsWe used data from a randomized trial evaluating universal versus risk-based PrEP delivery models at 20 antenatal clinics in Kenya (NCT03070600). Pregnant women enrolled were offered PrEP at any gestational age. A validated risk score for predicting HIV acquisition among perinatal women defined high HIV risk. HIV risk perception was assessed by asking "What is your gut feeling about how likely you are to get infected with HIV?" without a specified timeframe and dichotomized as low ("extremely/very unlikely") versus high ("extremely/somewhat likely/very likely"). All women in the universal PrEP offer arm were included in the analysis.

resultsAmong 2250 pregnant women, the median age was 24 years (interquartile range 21-28), 81% were married, and 22% did not know their partner's HIV status. Overall, 27% of women had high HIV risk scores of whom 61% self-perceived high risk. Among women with high HIV risk scores (n = 617), 69% declined PrEP; those who self-perceived low risk were more likely to decline than those with high risk perception (82% vs. 60%, adjusted prevalence ratio = 1.35, 95% confidence interval: 1.17-1.55, P < 0.001). Declining PrEP was associated with late gestational age at PrEP offer and with monogamous marriage among women with high HIV risk scores ( P < 0.05).

conclusionsDeclining PrEP was common among pregnant women with high HIV risk, especially those who self-perceived low HIV risk. Refining risk perception may encourage PrEP uptake.

Indexed as

Anti-HIV AgentsHealth Knowledge, Attitudes, PracticeHIV InfectionsPre-Exposure ProphylaxisPregnancy Complications, InfectiousPregnant PeoplePrenatal CareAdultFemaleHumansKenyaPregnancyYoung AdultAnti-HIV AgentsHIV risk perceptionpregnancyPrEP

Identifiers

PMID39885623
PMCPMC12265992

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.